Hypercoagulability impairs plaque stability in diabetes-induced atherosclerosis

Back

ESC Professional Premium Access

Hypercoagulability impairs plaque stability in diabetes-induced atherosclerosis

Session: Platelets and thrombomodulin

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Miss S. Ambreen (Leipzig, DE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Miss Saira Ambreen

University Hospital Leipzig, Leipzig (Germany)

0 follower

7 more presentations in this session

Human platelets and megakaryocytes express the BPIFB4 protein and their stimulation with the recombinant Longevity-associated variant LAV-BPIFB4 displays anti-aggregating activity.

Speaker: Doctor E. Ciaglia (Salerno, IT)

Pro-inflammatory sensitization of platelets after a mild course of COVID-19 infection

Speaker: Ms C. Tolksdorf (Oldenburg, DE)

Effects of the activated coagulation factor X (FXa) and its protease-activated receptor-2 (PAR2) on colon cancer cell growth in vitro and in vivo

Speaker: Professor B. Rauch (Oldenburg, DE)

S1P receptor-1 signaling reduces arterial thrombosis by upregulation of endothelial thrombomodulin expression

Speaker: Mrs M. Barcik (Duesseldorf, DE)

Direct oral anticoagulants versus vitamin K antagonists for left ventricular thrombus: a systematic review and meta-analysis

Speaker: Doctor L. KUBRUSLY (Curitiba, BR)

Access the full session

Platelets and thrombomodulin

Speakers: Miss S. Ambreen, Doctor E. Ciaglia, Ms C. Tolksdorf, Professor B. Rauch, Mrs M. Barcik...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Hypercoagulability impairs plaque stability in diabetes-induced atherosclerosis

About the speaker

Miss Saira Ambreen

7 more presentations in this session

Human platelets and megakaryocytes express the BPIFB4 protein and their stimulation with the recombinant Longevity-associated variant LAV-BPIFB4 displays anti-aggregating activity.

Pro-inflammatory sensitization of platelets after a mild course of COVID-19 infection

Effects of the activated coagulation factor X (FXa) and its protease-activated receptor-2 (PAR2) on colon cancer cell growth in vitro and in vivo

S1P receptor-1 signaling reduces arterial thrombosis by upregulation of endothelial thrombomodulin expression

Direct oral anticoagulants versus vitamin K antagonists for left ventricular thrombus: a systematic review and meta-analysis

Access the full session

Platelets and thrombomodulin

About the event

ESC Congress 2023

ESC 365 is supported by